These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Positive selection of cereblon modified function including its E3 ubiquitin ligase activity and binding efficiency with AMPK. Onodera W; Asahi T; Sawamura N Mol Phylogenet Evol; 2019 Jun; 135():78-85. PubMed ID: 30836149 [TBL] [Abstract][Full Text] [Related]
24. Avadomide induces degradation of ZMYM2 fusion oncoproteins in hematologic malignancies. Renneville A; Gasser JA; Grinshpun DE; Jean Beltran PM; Udeshi ND; Matyskiela ME; Clayton T; McConkey M; Viswanathan K; Tepper A; Guirguis AA; Sellar RS; Cotteret S; Marzac C; Saada V; De Botton S; Kiladjian JJ; Cayuela JM; Rolfe M; Chamberlain PP; Carr SA; Ebert BL Blood Cancer Discov; 2021 May; 2(3):250-265. PubMed ID: 34027417 [TBL] [Abstract][Full Text] [Related]
25. A mental retardation-linked nonsense mutation in cereblon is rescued by proteasome inhibition. Xu G; Jiang X; Jaffrey SR J Biol Chem; 2013 Oct; 288(41):29573-85. PubMed ID: 23983124 [TBL] [Abstract][Full Text] [Related]
26. [Recent topics in IMiDs and cereblon]. Ito T; Handa H Rinsho Ketsueki; 2017; 58(10):2067-2073. PubMed ID: 28978850 [TBL] [Abstract][Full Text] [Related]
27. [Development of novel cereblon modulators and their target molecules]. Ito T Rinsho Ketsueki; 2022; 63(6):573-579. PubMed ID: 35831190 [TBL] [Abstract][Full Text] [Related]
28. Structural basis of lenalidomide-induced CK1α degradation by the CRL4(CRBN) ubiquitin ligase. Petzold G; Fischer ES; Thomä NH Nature; 2016 Apr; 532(7597):127-30. PubMed ID: 26909574 [TBL] [Abstract][Full Text] [Related]
29. The novel cereblon modulator CC-885 inhibits mitophagy via selective degradation of BNIP3L. Hao BB; Li XJ; Jia XL; Wang YX; Zhai LH; Li DZ; Liu J; Zhang D; Chen YL; Xu YH; Lee SK; Xu GF; Chen XH; Dang YJ; Liu B; Tan MJ Acta Pharmacol Sin; 2020 Sep; 41(9):1246-1254. PubMed ID: 32210356 [TBL] [Abstract][Full Text] [Related]
30. UBE2G1 governs the destruction of cereblon neomorphic substrates. Lu G; Weng S; Matyskiela M; Zheng X; Fang W; Wood S; Surka C; Mizukoshi R; Lu CC; Mendy D; Jang IS; Wang K; Marella M; Couto S; Cathers B; Carmichael J; Chamberlain P; Rolfe M Elife; 2018 Sep; 7():. PubMed ID: 30234487 [TBL] [Abstract][Full Text] [Related]
31. A genome-scale CRISPR-Cas9 screening in myeloma cells identifies regulators of immunomodulatory drug sensitivity. Liu J; Song T; Zhou W; Xing L; Wang S; Ho M; Peng Z; Tai YT; Hideshima T; Anderson KC; Cang Y Leukemia; 2019 Jan; 33(1):171-180. PubMed ID: 30026574 [TBL] [Abstract][Full Text] [Related]
32. A Degron Blocking Strategy Towards Improved CRL4 Bouguenina H; Scarpino A; O'Hanlon JA; Warne J; Wang HZ; Wah Hak LC; Sadok A; McAndrew PC; Stubbs M; Pierrat OA; Hahner T; Cabry MP; Le Bihan YV; Mitsopoulos C; Sialana FJ; Roumeliotis TI; Burke R; van Montfort RLM; Choudhari J; Chopra R; Caldwell JJ; Collins I Chembiochem; 2023 Dec; 24(23):e202300351. PubMed ID: 37418539 [TBL] [Abstract][Full Text] [Related]
33. Computational investigations of indanedione and indanone derivatives in drug discovery: Indanone derivatives inhibits cereblon, an E3 ubiquitin ligase component. Nayek U; Basheer Ahamed SI; Mansoor Hussain UH; Unnikrishnan MK; Abdul Salam AA Comput Biol Chem; 2022 Dec; 101():107776. PubMed ID: 36252444 [TBL] [Abstract][Full Text] [Related]
34. Cereblon modulator CC-885 induces CRBN-dependent ubiquitination and degradation of CDK4 in multiple myeloma. Zhao M; Hu M; Chen Y; Liu H; Chen Y; Liu B; Fang B Biochem Biophys Res Commun; 2021 Apr; 549():150-156. PubMed ID: 33676183 [TBL] [Abstract][Full Text] [Related]
35. The Ubiquitination-Dependent and -Independent Functions of Cereblon in Cancer and Neurological Diseases. Zhou L; Xu G J Mol Biol; 2022 Mar; 434(5):167457. PubMed ID: 35045330 [TBL] [Abstract][Full Text] [Related]
36. Cereblon versus VHL: Hijacking E3 ligases against each other using PROTACs. Girardini M; Maniaci C; Hughes SJ; Testa A; Ciulli A Bioorg Med Chem; 2019 Jun; 27(12):2466-2479. PubMed ID: 30826187 [TBL] [Abstract][Full Text] [Related]
37. E3 Ligase Ligands for PROTACs: How They Were Found and How to Discover New Ones. Ishida T; Ciulli A SLAS Discov; 2021 Apr; 26(4):484-502. PubMed ID: 33143537 [TBL] [Abstract][Full Text] [Related]
38. Cereblon-Based Small-Molecule Compounds to Control Neural Stem Cell Proliferation in Regenerative Medicine. Sato T; Ito T; Handa H Front Cell Dev Biol; 2021; 9():629326. PubMed ID: 33777938 [TBL] [Abstract][Full Text] [Related]
39. Crbn-based molecular Glues: Breakthroughs and perspectives. An J; Zhang X Bioorg Med Chem; 2024 Apr; 104():117683. PubMed ID: 38552596 [TBL] [Abstract][Full Text] [Related]
40. The emerging role for Cullin 4 family of E3 ligases in tumorigenesis. Cheng J; Guo J; North BJ; Tao K; Zhou P; Wei W Biochim Biophys Acta Rev Cancer; 2019 Jan; 1871(1):138-159. PubMed ID: 30602127 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]